AEMPS — authorised 14 February 2022
- Marketing authorisation holder: GLOBAL BLOOD THERAPEUTICS NETHERLANDS B. V.
- Status: approved
🇪🇸 Oxbryta in Spain
AEMPS authorised Oxbryta on 14 February 2022
Marketing authorisation
Oxbryta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Spain
Frequently asked questions
Is Oxbryta approved in Spain?
Yes. AEMPS authorised it on 14 February 2022.
Who is the marketing authorisation holder for Oxbryta in Spain?
GLOBAL BLOOD THERAPEUTICS NETHERLANDS B. V. holds the Spanish marketing authorisation.